J.P. Morgan utilized Dealforma’s comprehensive data to compile their 2023 Annual Biopharma Licensing and Venture Report, highlighting key trends in funding, mergers, acquisitions, and more within the biopharma sector.
J.P. Morgan utilized Dealforma’s comprehensive data to compile their 2023 Annual Biopharma Licensing and Venture Report, highlighting key trends in funding, mergers, acquisitions, and more within the biopharma sector.
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
